Atlas Trials

A Voxelotor for Sickle Cell Anemia Patients at Highest Risk for Progression of Chronic Kidney Disease

Clinical trial NCT04335721 · TERMINATED

Trial details

NCT number
NCT04335721
Sponsor
University of Illinois at Chicago
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Sickle Cell DiseaseSickle Cell Nephropathy
Start date
2021-03-16
Primary completion
2024-10-07
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.